Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

23 results

Page 1 of 2

  • 11 - The Regulation of Human Germline Genome Modification in the Netherlands

  • from Part II - Europe
  • Edited by Andrea Boggio, Cesare P. R. Romano, Loyola Marymount University, California, Jessica Almqvist, Universidad Autónoma de Madrid
  • Book:
    Human Germline Genome Modification and the Right to Science
    Published online:
    15 November 2019
    Print publication:
    09 January 2020, pp 309-334

  • Summary

    In this chapter on human germline editing in The Netherlands, we first discuss the Dutch legal framework and the institutional environment regulating research involving human gametes and embryos. We then focus on legal provisions within the regulation of human germline editing. Here we show that within Dutch law, embryos and fetuses are not regarded as legal subjects with independent legal rights. However, unborn human life, even in early stages, is not treated as just a legal object either. With regard to human germline editing, two bans dominate the national legislative and policy framework: the ban on intentionally modifying the genetic material of the nucleus of human germline cells for reproductive purposes, and the ban on the creation of embryos for research. Finally, we offer an overview and analysis of current public and political debates on this technology in the light of the tensions between self-determination and reproductive autonomy on the one hand (the ‘medical ethics regime’), and human dignity and respect for human life on the other (the ‘human rights regime’). We conclude with our suggestion that, in order to make this debate more inclusive and balanced, both the human rights perspective and the medical-ethical perspective should be properly represented.

  • The Changing Nature of Law's Natural Person: The Impact of Emerging Technologies on the Legal Concept of the Person

  • Britta van Beers
  • Journal:
    German Law Journal / Volume 18 / Issue 3 / 01 May 2017
    Published online by Cambridge University Press:
    06 March 2019, pp. 559-594
    • Article
      • You have access
    • PDF
    • Export citation

  • This article discusses the legal concept of the person against the background of technological developments. Emerging technologies are offering radical ways to transform the biological and physical aspects of life. Several legal scholars claim that the technological artificialization of human life also calls for a more artificial, disembodied account of the natural person in law. According to them, the legal distinction between natural persons (human legal subjects) and artificial persons (non-human legal subjects, such as corporations) is becoming diluted and increasingly redundant. This article argues that, in an era of growing technological and postmodern disembodiment, the traditional legal distinction between natural and artificial persons remains important, albeit in a different form. An examination of the legal concept of the person in biomedical law suggests that law's category of the natural person still has its merits, not just despite these technological developments, but, remarkably enough, also because of them.

Personalised Medicine, Individual Choice and the Common Good
  • Edited by Britta van Beers, Sigrid Sterckx, Donna Dickenson
  • Published online:
    02 November 2018
    Print publication:
    22 November 2018
  • Hippocrates famously advised doctors 'it is far more important to know what person the disease has than what disease the person has'. Yet 2,500 years later, 'personalised medicine', based on individual genetic profiling and the achievements of genomic research, claims to be revolutionary. In this book, experts from a wide range of disciplines critically examine this claim. They expand the discussion of personalised medicine beyond its usual scope to include many other highly topical issues, including: human nuclear genome transfer ('three-parent IVF'), stem cell-derived gametes, private umbilical cord blood banking, international trade in human organs, biobanks such as the US Precision Medicine Initiative, direct-to-consumer genetic testing, health and fitness self-monitoring.Although these technologies often prioritise individual choice, the original ideal of genomic research saw the human genome as 'the common heritage of humanity'. The authors question whether personalised medicine actually threatens this conception of the common good.

  • Part II - Human rights and human dignity

  • Edited by Britta van Beers, Vrije Universiteit, Amsterdam, Luigi Corrias, Vrije Universiteit, Amsterdam, Wouter G. Werner, Vrije Universiteit, Amsterdam
  • Book:
    Humanity across International Law and Biolaw
    Published online:
    05 March 2014
    Print publication:
    13 February 2014, pp 133-220
    • Chapter
      • You have access
    • PDF
    • HTML
    • Export citation

Page 1 of 2